Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials

INTRODUCTION: Dalbavancin is a lipoglycopeptide antibiotic approved as a single- and two-dose regimen for adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive organisms. We present nephrotoxicity rates for patients with ABSSSI who received dalba...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Dis Ther
Main Authors: Gonzalez, Pedro L., Rappo, Urania, Mas Casullo, Veronica, Akinapelli, Karthik, McGregor, Jennifer S., Nelson, Jennifer, Nowak, Michael, Puttagunta, Sailaja, Dunne, Michael W.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7955009/
https://ncbi.nlm.nih.gov/pubmed/33515414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-021-00402-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados